Literature DB >> 12481236

[Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany].

A Erhardt1, I Theobald, W Petry, A Röhrborn, T Heintges, M Wettstein, D Häussinger.   

Abstract

BACKGROUND AND
OBJECTIVE: Hepatocellular carcinoma (HCC) ranks eighth among malignant tumors worldwide. Western countries belong to areas of low HCC prevalence, but incidence of HCC is rising. The aim of the present, retrospective study was to determine changes in the incidence rates and risk factors for HCC in Germany based on the data of a single center. PATIENTS AND METHODS: Epidemiological data of 205 consecutive patients with HCC (163 males, 42 females, mean age 64+/-1 years), admitted to the University clinic Düsseldorf between January 1988 and December 2001, were evaluated. For comparison this time period was divided into two equal intervals (1988 - 1994 and 1995 - 2001).
RESULTS: The number of newly diagnosed HCC has more than doubled in the years 1995 - 2001 compared to the years 1988 - 1994. Chronic hepatitis C (HCV), hepatitis B (HBV), and chronic alcohol abuse accounted for almost 80 % of HCC. The number of HCV-associated HCC increased from 31.0 % in the years 1990 - 1995 to 44.6 % (p < 0.04) in the years 1996 - 2001, whereas the proportion of HBV-associated HCC decreased. There were no changes in the Okuda tumor stage, tumor diameter and alpha-fetoprotein levels at the time of HCC diagnosis throughout the years 1988 - 2001. More than 65 % of HCC were non-resectable at the time of HCC diagnosis due to tumor diameter or number of tumor lesions.
CONCLUSION: Screening for HCC, possibly rising in its incidence, should be further improved, taking into account that chronic HCV infection is the major risk factor for HCC in Germany.

Entities:  

Mesh:

Year:  2002        PMID: 12481236     DOI: 10.1055/s-2002-36118

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  5 in total

Review 1.  [Ultrasound contrast agents for liver diagnostics].

Authors:  A-J Lemke; S S Chopra; S M Niehues; R Felix
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

2.  New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.

Authors:  Thomas Göbel; Sonja Vorderwülbecke; Katarzyna Hauck; Holger Fey; Dieter Häussinger; Andreas Erhardt
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 3.  [Genome-wide molecular screening for the identification of new targets in human hepatocellular carcinoma].

Authors:  T Longerich
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

4.  Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.

Authors:  T F Greten; F Papendorf; J S Bleck; T Kirchhoff; T Wohlberedt; S Kubicka; J Klempnauer; M Galanski; M P Manns
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

Review 5.  Hepatocellular carcinoma in the world and the middle East.

Authors:  H Poustchi; Sg Sepanlou; S Esmaili; N Mehrabi; A Ansarymoghadam
Journal:  Middle East J Dig Dis       Date:  2010-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.